Antimicrobial Susceptibility of Canine and Human Staphylococcus aureus Collected in Saskatoon, Canada

Zoonoses and Public Health

Volumn 58, Issue 7, 2011, Pages 454-462

  Rubin, J E ^a   Chirino Trejo, M ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Antimicrobial resistance; Canine; Human; MRSA; Staphylococcus aureus; Zoonotic

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFTIOFUR; CHLORAMPHENICOL; CHLORTETRACYCLINE; CIPROFLOXACIN; CLINDAMYCIN; DALFOPRISTIN; DANOFLOXACIN; DAPTOMYCIN; ERYTHROMYCIN; GEMIFLOXACIN; GENTAMICIN; LINEZOLID; MOXIFLOXACIN; NEOMYCIN; NITROFURANTOIN; OXACILLIN; OXYTETRACYCLINE; PENICILLIN G; PSEUDOMONIC ACID; QUINUPRISTIN; RIFAMPICIN; TELITHROMYCIN; TETRACYCLINE; TILMICOSIN; TULATHROMYCIN; TYLOSIN; UNINDEXED DRUG; VANCOMYCIN;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CANADA; CANINE ADENOVIRUS; CELL CULTURE; CONTROLLED STUDY; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DOG; GENE; HUMAN; HUMAN CELL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SPECIES COMPARISON; STAPHYLOCOCCUS AUREUS; VETERINARY MEDICINE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CANADA; DOG DISEASES; DOGS; DRUG RESISTANCE, BACTERIAL; EXOTOXINS; HUMANS; LEUKOCIDINS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

CANIS FAMILIARIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 80053930962     PISSN: 18631959     EISSN: 18632378     Source Type: Journal    
DOI: 10.1111/j.1863-2378.2011.01392.x     Document Type: Article

References (36)

1. Abramson, M. A., and D. J. Sexton, 1999: Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect. Control Hosp. Epidemiol. 20, 408-411.
2. Andrews, J. M., 2008: BSAC standardized disc susceptibility testing method (version 7). J. Antimicrob. Chemother. 62, 256-278.
3. Ball, K. R., J. E. Rubin, M. Chirino-Trejo, and P. M. Dowling, 2008: Antimicrobial resistance and prevalence of canine uropathogens at the Western College of Veterinary Medicine Veterinary Teaching Hospital, 2002-2007. Can. Vet. J. 49, 985-990.
4. Canada, G. O., 2007: Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2005. Public Health Agency of Canada, Guelph, ON.
5. Canada, G. O., 2008: Surveillance for Methicillin-resistant Staphylococcus aureus (MRSA) in Patients Hospitalized in Canadian Acute-Care Hospitals Participating in CNISP 2006-2007 Preliminary Results. Public Health Agency of Canada, Ottawa, ON.
6. CLSI, 2008a: Performance Standards for Antimicrobial Disk and Dilution Susceptiblity Tests for Bacteria Isolated From Animals. M31-A3. Clinical and Laboratory Standards Institute, Wayne, PA, USA.
7. CLSI, 2008b: Performance Standards for Antimicrobial Susceptibility Testing. M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA, USA.
8. Dancer, S. J., 2008: The effect of antibiotics on methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 61, 246-253.
9. Enoch, D. A., J. A. Karas, and S. H. Aliyu, 2009: Oral antimicrobial options for the treatment of skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in the UK. Int. J. Antimicrob. Agents 33, 497-502.
10. Faires, M. C., S. Gard, D. Aucoin, and J. S. Weese, 2009a: Inducible clindamycin-resistance in methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius isolates from dogs and cats. Vet. Microbiol. 139, 419-420.
11. Faires, M. C., K. C. Tater, and J. S. Weese, 2009b: An investigation of methicillin-resistant Staphylococcus aureus colonization in people and pets in the same household with an infected person or infected pet. J. Am. Vet. Med. Assoc. 235, 540-543.
12. Faires, M. C., M. Traverse, K. C. Tater, D. L. Pearl, and J. S. Weese, 2010: Methicillin-resistant and -susceptible Staphylococcus aureus infections in dogs. Emerg. Infect. Dis. 16, 69-75.
13. FDA, 2007: NARMS 2007 Retail Meat Annual Complete Report. FDA, Rockville, MD.
14. Finks, J., E. Wells, T. L. Dyke, N. Husain, L. Plizga, R. Heddurshetti, M. Wilkins, J. Rudrik, J. Hageman, J. Patel, and C. Miller, 2009: Vancomycin-resistant Staphylococcus aureus, Michigan, USA, 2007. Emerg. Infect. Dis. 15, 943-945.
15. Kashiwamura, M., E. Chida, M. Matsumura, Y. Nakamaru, N. Suda, Y. Terayama, and S. Fukuda, 2004: The efficacy of Burow's solution as an ear preparation for the treatment of chronic ear infections. Otol. Neurotol. 25, 9-13.
16. Labandeira-Rey, M., F. Couzon, S. Boisset, E. L. Brown, M. Bes, Y. Benito, E. M. Barbu, V. Vazquez, M. Hook, J. Etienne, F. Vandenesch, and M. G. Bowden, 2007: Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 315, 1130-1133.
17. Laupland, K. B., T. Ross, and D. B. Gregson, 2008: Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J. Infect. Dis. 198, 336-343.
18. Lina, G., Y. Piemont, F. Godail-Gamot, M. Bes, M. O. Peter, V. Gauduchon, F. Vandenesch, and J. Etienne, 1999: Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29, 1128-1132.
19. Loffler, B., M. Hussain, M. Grundmeier, M. Bruck, D. Holzinger, G. Varga, J. Roth, B. C. Kahl, R. A. Proctor, and G. Peters, 2010: Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog. 6, e1000715.
20. Manian, F. A., 2003: Asymptomatic nasal carriage of mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contacts. Clin. Infect. Dis. 36, e26-e28.
21. McConeghy, K. W., D. J. Mikolich, and K. L. Laplante, 2009: Agents for the decolonization of methicillin-resistant Staphylococcus aureus. Pharmacotherapy 29, 263-280.
22. Mulvey, M. R., L. MacDougall, B. Cholin, G. Horsman, M. Fidyk, and S. Woods, 2005: Community-associated methicillin-resistant Staphylococcus aureus, Canada. Emerg. Infect. Dis. 11, 844-850.
23. de Neeling, A. J., W. J. van Leeuwen, L. M. Schouls, C. S. Schot, A. van Veen-Rutgers, A. J. Beunders, A. G. Buiting, C. Hol, E. E. Ligtvoet, P. L. Petit, L. J. Sabbe, A. J. van Griethuysen, and J. D. van Embden, 1998: Resistance of staphylococci in The Netherlands: surveillance by an electronic network during 1989-1995. J. Antimicrob. Chemother. 41, 93-101.
24. Rubin, J. E., and M. Chirino-Trejo, 2010: Pharyngeal, rectal and nasal colonization of clinically healthy dogs with Staphylococcus aureus. Vet. Microbiol. 143, 440-441.
25. Rubin, J. E., and M. C. Gaunt, in press: Urinary tract infection caused by methicillin-resistant Staphylococcus pseudintermedius in a dog. Can. Vet. J.
26. Rubin, J. E., K. R. Ball, and M. Chirino-Trejo, in press: Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus pseudintermedius isolated from various veterinary species. Can. Vet. J.
27. Siberry, G. K., T. Tekle, K. Carroll, and J. Dick, 2003: Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin. Infect. Dis. 37, 1257-1260.
28. Simor, A. E., T. L. Stuart, L. Louie, C. Watt, M. Ofner-Agostini, D. Gravel, M. Mulvey, M. Loeb, A. McGeer, E. Bryce, and A. Matlow, 2007: Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrob. Agents Chemother. 51, 3880-3886.
29. Simor, A. E., N. L. Gilbert, D. Gravel, M. R. Mulvey, E. Bryce, M. Loeb, A. Matlow, A. McGeer, L. Louie, and J. Campbell, 2010: Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: National Surveillance and Changing Epidemiology, 1995-2007. Infect. Control Hosp. Epidemiol. 31, 348-356.
30. Song, J. H., 2008: What's new on the antimicrobial horizon? Int. J. Antimicrob. Agents 32(Suppl. 4), S207-S213.
31. Stenstrom, R., E. Grafstein, M. Romney, J. Fahimi, D. Harris, G. Hunte, G. Innes, and J. Christenson, 2009: Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department. CJEM 11, 430-438.
32. Weber, S. G., H. S. Gold, D. C. Hooper, A. W. Karchmer, and Y. Carmeli, 2003: Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg. Infect. Dis. 9, 1415-1422.
33. Weese, J. S., 2008: Issues regarding the use of vancomycin in companion animals. J. Am. Vet. Med. Assoc. 233, 565-567.
34. Weese, J. S., and E. van Duijkeren, 2010: Methicillin-resistant Staphylococcus aureus and Staphylococcus pseudintermedius in veterinary medicine. Vet. Microbiol. 140, 418-429.
35. Winn, W., S. Allen, W. Janda, E. Koneman, G. Procop, P. Schreckenberger, and G. Woods, 2006: Koneman's Color Atlas and Textbook of Diagnostic Microbiology. Lippincott Williams & Wilkins, Baltimore, MD.
36. Woodford, N., 2005: Biological counterstrike: antibiotic resistance mechanisms of Gram-positive cocci. Clin. Microbiol. Infect. 11(Suppl. 3), 2-21.